Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in the Centre for OA Pathogenesis Versus Arthritis at the Kennedy Institute of Rheumatology and Imperial College London are looking to recruit adults with painful hand osteoarthritis for an observational study to help uncover why people living with the condition experience different patterns of pain.

Elderly Person With Painful Hand © Shutterstock

Hand osteoarthritis is a common condition that affects more than 2 million people in the UK, affecting 1 in 4 people aged 50 years and over.

The Versus Arthritis-funded HOPE-c study is recruiting members aged 18 years old and over that live in the UK and have hand pain due to osteoarthritis. The study aims to answer the following questions: 

  • Are there different patterns of pain in hand osteoarthritis?
  • Can we identify factors that predict the future course of pain in hand osteoarthritis? 
  • Why do some people experience flares but not others? How does a flare impact a person’s life?

Participants will primarily be assessed remotely with optional face-to-face visits for participants who live near the main sites in Oxford and London (only when it is safe and feasible to do so, depending on local COVID-19 restrictions). A minimum of 5 assessments (electronic surveys) are carried over 26 weeks with up to three additional assessments if there are Flares/Changes in hand symptoms. These assessments include patient-reported questionnaires to assess pain, function, hormonal symptoms and mood with opportunities to submit hand photographs and x-rays. Participants will also be asked to score hand pain daily for six months, either using their mobile phone (using a secure weblink sent by daily SMS) or a paper diary. There is an optional follow-up for consenting patients at Year 2 and Year 5. 

The study is recruiting participants until September 2022. More information on taking part can be found on the HOPE-c website.

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.